cell_type

ASTROCYTE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ASTROCYTE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4766Connections

30Hypotheses

1Analyses

50Outgoing

50Incoming

12Experiments

1Debates

Summary

Astrocytes are the most abundant glial cells in the CNS, performing critical roles in blood-brain barrier maintenance, neurotransmitter recycling (glutamate uptake via GLT-1), metabolic support (astrocyte-neuron lactate shuttle), ion homeostasis (K+ buffering), and synapse formation/pruning. Astrocytes form the glymphatic system, a brain-wide waste clearance network that removes amyloid-beta and tau during sleep via AQP4 water channels. In neurodegeneration, astrocytes become reactive: A1 astrocytes (induced by microglia via TNF-alpha, IL-1alpha, C1q) are neurotoxic, while A2 astrocytes are neuroprotective. Reactive astrogliosis is a hallmark of AD, PD, ALS, and MS. Therapeutic targeting of astrocyte reactivity, glutamate transport, and glymphatic function are active research areas.

View on Wiki →

AI-generated illustration

Regenerate portrait ↻

🧫 Cell Type Info

Cell Type	ASTROCYTE
Definition	Astrocytes are star-shaped glial cells that provide metabolic and structural support to neurons, regulate neurotransmission, maintain the blood-brain barrier, and respond to neural injury.
Key Markers	GFAP, AQP4, ALDH1L1, S100B
Key Pathways	Apoptosis, Autophagy, Blood-Brain Barrier, Complement, Mtor
Associated Diseases	Aging, Als, Alzheimer, Cancer, Depression, Inflammation
Linked Hypotheses	334 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Astrocyte Reactivity Mechanism

mechanism · 4559 words

→

Pathway Diagram

graph TD
    ASTROCYTE["ASTROCYTE"]
    ASTROCYTE -->|"implicated in"| Alzheimer_s_disease["Alzheimer's disease"]
    ASTROCYTE -->|"interacts"| MICROGLIA["MICROGLIA"]
    ASTROCYTE -->|"expressed in"| C3["C3"]
    ASTROCYTE -->|"activates"| Neuroinflammation["Neuroinflammation"]
    ASTROCYTE -->|"causes"| Inflammation["Inflammation"]
    ASTROCYTE -->|"causes"| Multiple_Sclerosis["Multiple Sclerosis"]
    ASTROCYTE -->|"causes"| ALS["ALS"]
    ASTROCYTE -->|"causes"| Autoimmune["Autoimmune"]
    ASTROCYTE -->|"causes"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    BMAL1["BMAL1"] -->|"expressed in"| ASTROCYTE
    LC3B["LC3B"] -->|"expressed in"| ASTROCYTE
    MAP1LC3B["MAP1LC3B"] -->|"expressed in"| ASTROCYTE
    CB2R["CB2R"] -->|"expressed in"| ASTROCYTE
    APOE["APOE"] -->|"regulates"| ASTROCYTE
    NRF2["NRF2"] -->|"expressed in"| ASTROCYTE
    NOX4["NOX4"] -->|"expressed in"| ASTROCYTE
    STAT3["STAT3"] -->|"regulates"| ASTROCYTE

Outgoing (2323)

Target	Relation	Type	Str
Als	activates	disease	1.00
Inflammation	activates	disease	1.00
MICROGLIA	activates	gene	1.00
Aging	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
Stem Cell	activates	pathway	1.00
NEURON	activates	cell_type	1.00
Neurodegeneration	therapeutic_target	disease	1.00
Cancer	activates	disease	1.00
Als	therapeutic_target	disease	1.00
Inflammation	causes	disease	1.00
Neurodegeneration	regulates	disease	1.00
Nf-Κb	activates	pathway	1.00
Depression	activates	disease	1.00
Neuroinflammation	activates	disease	1.00
Inflammation	regulates	disease	1.00
Alzheimer	activates	disease	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
Stroke	activates	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
Multiple sclerosis	associated_with	disease	1.00
AKT	activates	gene	1.00
Apoptosis	activates	pathway	1.00
Oxidative Stress	activates	pathway	1.00
DEPRESSION	activates	gene	1.00
Neuroinflammation	causes	disease	0.95
Anxiety	activates	disease	0.95
Epilepsy	activates	disease	0.95
Neuroinflammation	therapeutic_target	disease	0.95
Neurodegeneration	causes	disease	0.95
Als	expressed_in	disease	0.95
Alzheimer'S Disease	involved_in	disease	0.95
Glymphatic System	involved_in	process	0.95
Neuroinflammation	regulates	disease	0.95
Neurotoxic Astrocyte Reactivity	involved_in	phenotype	0.95
Als	regulates	disease	0.95
Parkinson	activates	disease	0.95
Neuroprotective Astrocyte Reactivity	involved_in	phenotype	0.95
Alzheimer	regulates	disease	0.95
Inflammation	therapeutic_target	disease	0.95
Autoimmune	activates	disease	0.95
Neuroinflammation	mediates	process	0.90
Excitotoxicity	mediates	process	0.90
Synaptic Dysfunction	contributes_to	phenotype	0.90
neurodegenerative stress response	involved_in	process	0.90
CHI3L1	product_of	protein	0.90
Microglia	interacts_with	cell_type	0.90
Active Lesion Rim	involved_in	phenotype	0.90
Chi3l1/YKL-40	regulates	protein	0.90
Alzheimer's Disease Continuum	involved_in	disease	0.90

Incoming (2443)

Source	Relation	Type	Str
ASTROCYTES	associated_with	gene	1.00
NEURODEGENERATION	activates	gene	1.00
ASTROCYTES	therapeutic_target	gene	1.00
NF-ΚB	activates	gene	1.00
GENES	activates	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
CYTOKINES	activates	gene	1.00
ASTROCYTES	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
ASTROCYTES	inhibits	gene	1.00
ALZHEIMER	activates	gene	1.00
TNF-Α	activates	gene	1.00
TNF	activates	gene	1.00
ASTROCYTES	regulates	gene	1.00
CANCER	activates	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
STAT3	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
ASTROCYTES	causes	gene	1.00
MYELIN	activates	gene	1.00
necroptosis	causes	process	0.95
SNCA	activates	protein	0.90
TNF	modulates	protein	0.90
THYROID HORMONE	regulates	entity	0.90
GFAP	expressed_in	gene	0.90
COMPLEMENT CASCADE	causes	entity	0.90
biomarkers-astrocyte-exosomal-mrna-reference-genes	describes	wiki	0.90
GJA1	expressed_in	protein	0.90
IL-6	promotes_apoptosis	protein	0.90
SAPAP3	expressed_in	gene	0.90
APOE4	disrupts	gene	0.90
LACCER	upregulated_in	compound	0.90
C3	secreted_by	protein	0.90
BST2	expressed_in	gene	0.90
CHI3L1	secreted_by	protein	0.90
EPILEPSY	activates	gene	0.90
NEURODEGENERATION	causes	gene	0.90
ALS	activates	gene	0.90
ASTROCYTES	interacts_with	gene	0.90
PARKINSON	activates	gene	0.90
ALZHEIMER	regulates	gene	0.90
PI3K	activates	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.90
ASTROCYTES	expressed_in	gene	0.90
proinflammatory cytokines	modulates	pathway	0.87
MCT8	regulates	entity	0.85
TNBC	interacts_with	disease	0.85
OREXIN-A	inhibits	compound	0.80
reactive_astrocyte	associated_with	cell_type	0.80

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen	0.990	neurodegeneration	TREM2 in Alzheimer's Disease: Mechanisms
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene	0.907	neurodegeneration	Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener	0.892	neurodegeneration	Gene expression changes in aging mouse b
Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte	0.839	neurodegeneration	View
Beta-frequency entrainment therapy targeting PV interneuron-	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
AMPK hypersensitivity in astrocytes creates enhanced mitocho	0.813	neurodegeneration	Mitochondrial transfer between astrocyte
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC	0.760	neuroscience	APOE4-driven lipid metabolism dysregulat
GFAP-Positive Reactive Astrocyte Subtype Delineation	0.754	Alzheimer's Disease	SEA-AD Gene Expression Profiling — Allen
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate	0.750	Alzheimer's disease, Parkinson's disease	-
Adenosine-Astrocyte Metabolic Reset	0.730	neurodegeneration	Sleep disruption as cause and consequenc
Astrocyte-Mediated Neuronal Epigenetic Rescue	0.725	neurodegeneration	Epigenetic reprogramming in aging neuron
Circadian Rhythm Entrainment of Reactive Astrocytes	0.722	neurodegeneration	Astrocyte reactivity subtypes in neurode
H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astroc	0.720	neurodegeneration	Do APOE4-driven senescent astrocytes cau
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.710	neuroscience	APOE4-driven lipid metabolism dysregulat
H4: Senomorphic Compounds Preserve Astrocyte Function While	0.710	neurodegeneration	Do APOE4-driven senescent astrocytes cau
Astrocyte-Neuron Metabolic Coupling Titration	0.704	metabolic neuroscience	What determines the optimal timing and d
Calcium-Dependent S100B Release from Astrocyte End-Feet as a	0.700	-	What blood-brain barrier permeability ch
Astrocyte-Neuron Metabolic Coupling Failure Precedes Neurode	0.690	neurodegeneration	Gap 006 analysis (archived stub)
Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vuln	0.690	neurodegeneration	Cell type vulnerability debate in Alzhei
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles	0.682	neurodegeneration	Which cell types show the most significa
CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of A	0.680	-	What blood-brain barrier permeability ch
Astrocyte-Mediated Microglial Memory Erasure	0.677	-	Neuroinflammation and microglial priming
AQP4-Dependent Astrocyte Swelling Exacerbates Excitotoxic Ne	0.670	neurodegeneration	What are the specific molecular mechanis
TREM2 R47H variant synergizes with APOE4 to collapse microgl	0.670	neuroscience	APOE4-driven lipid metabolism dysregulat
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli	0.668	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Astrocyte IL-1β as Paracrine Mediator of Microglial Compleme	0.660	neuroinflammation	How does sevoflurane-induced NF-κB activ
Blood Astrocyte-Derived Exosomal AQP4 Mislocalization Predic	0.660	-	What blood-brain barrier permeability ch
Astrocyte-Microglia Communication Rebalancing via Cytokine M	0.655	neurodegeneration	Which cell types show the most significa
XOR+ stress-responsive astrocytes represent a novel AD-assoc	0.000	Alzheimer's disease	scRNA-seq Processing and Cell Type Annot

Mentioning Analyses (1)

Scientific analyses that reference this entity

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847

Experiments (12)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD	exploratory	Parkinson's disease	0.900	0.00	iPSC-derived dopaminergic neur	proposed	N/A
iPSC-NPC effects on astrocytes in vitro ICH model	exploratory	intracerebral hemorrhage	0.900	0.00	in vitro ICH cell culture mode	completed	N/A
Cognitive impact of TDP-43 pathology in AD patients	clinical	Alzheimer's disease	0.700	0.00	human patients	completed	N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an	falsification	Neurodegeneration	0.400	0.50	cell_line	completed	$100,000
Metabolic Pathway-Targeted Therapy in ALS	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Animal Model Comparison for Neurodegenerative Disease Therapeutics	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,100,000
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso	validation	Parkinson's Disease	0.400	0.50	human	proposed	$3,000,000
Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec	validation	Neurodegeneration	0.400	0.50	cell_line	proposed	$160,000
GLP-1 Agonist Neuroprotection Mechanism in PD	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Recept [PMID:28709002]	Nabet BY, Qiu Y, Shabason JE, Wu TJ, Yoo	Cell	2017	412
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655]	Jorstad NL, Close J, Johansen N, Yanny A	Science	2023	186
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614]	Han QQ, Shen SY, Liang LF, Chen XR, Yu J	Brain Behav Immun	2024	1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704]	Zhang T, Xu D, Trefts E, Lv M, Inuzuka H	Science	2023	1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797]	Zhou Y, Song WM, Andhey PS, Swain A, Lev	Nat Med	2020	1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892]	Wang Y, An H, Liu T, Qin C, Sesaki H, Gu	Cell Rep	2019	1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310]	Song X, Zhu S, Chen P, Hou W, Wen Q, Liu	Curr Biol	2018	1
Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuro [PMID:26121488]	Hang L, Thundyil J, Lim KL	Ann N Y Acad Sci	2015	1
Independent and interactive contributions of white matter hyperintensities and A [PMID:41906163]	Dario Bachmann; Christoph Gericke; Maha	Alzheimer's research & the	2026	0
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188]	Cetindag AC, Schipke CG, Esselmann H, Kr	The journal of prevention of A	2026	0
AMPKα1 Deficiency in Macrophages Impairs Tendon Regeneration and Tendon Stem Cel [PMID:41694579]	Zhu L, Wang Y, Shi X, Yu M, Cai X, Chen	International journal of biolo	2026	0
Single-cell transcriptome analysis reveals a cellular immune response in common [PMID:41692207]	Shi X, Ji G, Liu D, Zhao T, Tian S, Li S	International journal of biolo	2026	0
Farrerol ameliorates hepatic insulin resistance via AMPKα1/mTOR/SREBP-1 pathway: [PMID:41702183]	Li Y, Feng X, Zheng L	Tissue & cell	2026	0
Biomarkers for Alzheimer's disease across diverse biological domains: an umbrell [PMID:40680830]	Kang J, Son Y, Yim Y, Cho H, Kim J et al	J Adv Res	2026	0
Potential diagnostic markers in Alzheimer's disease: current perspectives and fu [PMID:40911035]	Zheng M, Wang S, Jia J	Neurodegener Dis Manag	2026	0
MAO-B status in alcohol use disorder: a [(11)C]SL25.1188 PET imaging study of pu [PMID:41291188]	Best LM, Truong J, McCluskey T, Meyer JH	Mol Psychiatry	2026	0
Association between sleep duration and fluid biomarkers of Alzheimer's disease: [PMID:41610733]	Young VM, Zeynoun J, Ruiz Laza A, Salard	Sleep Med Rev	2026	0
Injectable anti-inflammatory, antioxidant supramolecular nanofiber hydrogel for [PMID:41624514]	Liu A, Sheng K, Li H, Zhao X, Zhang X et	Mater Today Bio	2026	0
NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopat [PMID:41650822]	López-Sampere Y, Mengod Soler P, Roca-Pe	Redox Biol	2026	0
Decoding Alzheimer's disease through down syndrome: insights from a genetically [PMID:41709686]	Russell JK, Schlachetzki Z, Rafii MS	Curr Opin Neurol	2026	0

Debates (1)

Multi-agent debates referencing this entity

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

closed · Rounds: 4 · Score: 0.90 · 2026-04-03

Related Research

Hypotheses and analyses mentioning ASTROCYTE in their description or question text

ASTROCYTE

Understanding Entity Pages

Summary

Wiki Pages (1)

Astrocyte Reactivity Mechanism

Pathway Diagram

Outgoing (2323)

Incoming (2443)

Targeting Hypotheses (30)

Mentioning Analyses (1)

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Experiments (12)

Related Papers (20)

Debates (1)

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

Related Research

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue respon

APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporter

GFAP-Positive Reactive Astrocyte Subtype Delineation

Adenosine-Astrocyte Metabolic Reset

Astrocyte-Mediated Neuronal Epigenetic Rescue

Circadian Rhythm Entrainment of Reactive Astrocytes

H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astrocyte Senescence

Selective LXRβ agonists restore ABCA1/ABCG1 expression and APOE lipidation in AP

H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence

Astrocyte-Neuron Metabolic Coupling Titration

Calcium-Dependent S100B Release from Astrocyte End-Feet as an Early Signal of As

Astrocyte-Neuron Metabolic Coupling Failure Precedes Neurodegeneration in FTD-GR

Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vulnerability